Author Archives: cdgips2

Sadek et al., 2024. Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine. Neuropharmacology, https://doi.org/10.1016/j.neuropharm.2023.109816

Tyrone received a Society for Research on Nicotine and Tobacco (SRNT) Registration
Scholarship to present his work at the upcoming SRNT meeting in Edinburgh, Scotland

Tyrone Kendrick and Ashley White presented posters, and Dr. Gipson-Reichardt chaired and presented in a xylazine/fentanyl panel with Drs. Joseph Palamar and Justin Strickland.

We wish Shailesh Khatri good luck as he transitions to open his own lab at Oklahoma State University! Congrats!

November 2023: Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanyl

https://www.nature.com/npp/podcast

Congratulations to Mary Beth Matocha and Violet Newhart for their successful poster presentations at the SURES 2023 poster session!

Congratulations to Tyrone for his travel award from NIDA!

And congratulations to Tyrone for giving his first talk at CPDD!